- Report
- June 2024
- 120 Pages
North America
From €3543EUR$3,869USD£3,017GBP
- Report
- January 2022
- 249 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- June 2023
- 347 Pages
Global
From €4802EUR$5,427USD£3,950GBP
- Report
- January 2022
- 176 Pages
Global
From €4395EUR$4,799USD£3,742GBP
- Report
- January 2024
- 235 Pages
Global
From €4533EUR$4,950USD£3,860GBP
- Report
- May 2023
United States
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2023
Germany
From €1374EUR$1,500USD£1,170GBP
- Report
- January 2024
- 92 Pages
Europe
From €2702EUR$2,950USD£2,300GBP
- Report
- November 2022
- 178 Pages
United States
From €2404EUR$2,625USD£2,047GBP
€4808EUR$5,250USD£4,094GBP
- Report
- May 2022
- 244 Pages
Global
From €2404EUR$2,625USD£2,047GBP
€4808EUR$5,250USD£4,094GBP
- Report
- December 2021
- 286 Pages
Global
From €2404EUR$2,625USD£2,047GBP
€4808EUR$5,250USD£4,094GBP
- Report
- March 2024
- 128 Pages
Global
From €2981EUR$3,255USD£2,538GBP
€4259EUR$4,650USD£3,626GBP
- Report
- October 2021
- 156 Pages
Global
From €3526EUR$3,850USD£3,002GBP
€5037EUR$5,500USD£4,288GBP
- Report
- November 2023
- 183 Pages
United States
From €3617EUR$3,950USD£3,080GBP
- Report
- April 2024
- 183 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- April 2024
- 185 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- November 2023
- 190 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- November 2023
- 190 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- August 2023
- 173 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- June 2023
- 116 Pages
Global
From €4121EUR$4,500USD£3,509GBP

The Cancer Genetics market is a subset of the Genomics market, focusing on the study of genetic mutations associated with cancer. This includes the identification of genetic markers that can be used to diagnose, monitor, and treat cancer. It also includes the development of targeted therapies and personalized medicine. Cancer Genetics research is conducted through a variety of methods, such as sequencing, bioinformatics, and gene expression analysis.
The Cancer Genetics market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for personalized medicine. Additionally, the increasing availability of genomic data and the development of new technologies are expected to drive the market in the future.
Some companies in the Cancer Genetics market include Illumina, Thermo Fisher Scientific, BGI, QIAGEN, and Agilent Technologies. Show Less Read more